Table 1.
Characteristic | #Patients/Procedures (%) |
---|---|
Patient age, y | |
<65 | 1,321,840 (63.2%) |
≥65 | 769,752 (36.8%) |
BMI | |
<25 | 289,219 (13.8%) |
≥ 25 to < 30 (overweight) | 471,098 (22.5%) |
≥ 30 to < 35 (Class I obesity) | 321,363 (15.4%) |
≥ 35 to < 40 (Class II obesity) | 130,845 (6.3%) |
≥ 40 (Class III obesity) | 66,553 (3.2%) |
Missing | 812,514 (38.9%) |
Gender | |
Male | 1,973,369 (94.3%) |
Female | 118,221 (5.7%) |
Obstructive Sleep Apnea | |
Yes | 121,154 (5.8%) |
No | 1,970,438 (94.2%) |
Drug/Alcohol Abuse or Dependence | |
Yes | 218,543 (10.4%) |
No | 1,873,049 (89.6%) |
Opioid Script Filled ≤6 months | |
Yes | 402,184 (19.2%) |
No | 1,689,408 (80.8%) |
Benzodiazepine Script Filled ≤6 months | |
Yes | 97,899 (4.7%) |
No | 1,993,693 (95.3%) |
Charlson-Deyo Comorbidity Score | |
0 | 1,175,693 (56.2%) |
1–2 | 655,360 (31.3%) |
≥3 | 260,539 (12.5%) |
Endoscopy Location | |
Non-GI Suite/Clinic | 325,240 (15.5%) |
GI Suite/Clinic | 1,766,352 (84.5%) |
Endoscopist Specialty | |
Gastroenterologist | 1,439,884 (68.8%) |
Non-gastroenterologist | 651,708 (31.2%) |
Type of Procedure | |
EGD | 643,186 (27.5%) |
Colonoscopy | 1,694,204 (72.5%) |